Researchers at Umeå University have discovered a mechanism in which chemical marks on RNA control a DNA methylation enzyme to help silence tumor-suppressor genes in ovarian cancer cells, according to a study published in Medical Xpress.
The findings identify a link between two gene-regulation systems in high-grade serous ovarian carcinoma, the most lethal subtype of the disease.
According to Science Advances, the study was authored by Kanchan Kumari, Iván Pérez-Núñez, Aleix Noguera Castells and 12 other researchers, and was published Nov. 6. The work details an oncogenic role for the RNA methyltransferase METTL3 and the N 6 -methyladenosine (m 6 A) RNA modification pathway in high-grade serous ovarian carcinoma.
The study shows that METTL3 increases the production of DNMT1, an enzyme that methylates DNA and keeps tumor-suppressor genes switched off. METTL3 adds a chemical modification to messenger RNA carrying instructions for producing DNMT1, allowing more DNMT1 protein to be produced without increasing the amount of messenger RNA.
“Cancer cells can exploit processes that are normally required for cells to function properly and use them to promote uncontrolled growth and spread,” Kumari said.
said Kanchan Kumari, a postdoctoral researcher at the Department of Molecular Biology at Umeå University and the first and co-corresponding author of the study.
When METTL3 was inhibited in cell-based experiments and animal models, ovarian cancer cell growth and colony formation decreased. In a mouse model, suppressing METTL3 delayed tumor development and reduced growth. Inhibiting DNMT1 decreased genome-wide DNA methylation and increased the activity of tumor-suppressor genes, including TNFAIP3 and FBXO32.
“Understanding the fundamental mechanisms of gene regulation is essential if we want to understand how a cell works and what goes wrong in cancer. If we do not understand the machinery, how can we hope to target it? In the long term, basic research can contribute to new treatment strategies,” said Francesca Aguilo, an associate professor in Umeå University’s Department of Molecular Biology who also led the research as principal investigator.
commented Francesca Aguilo, the principal investigator and associate professor at Umeå University’s Department of Molecular Biology.
Umeå University, founded in 1965 as the fifth university within Sweden’s present borders, is a public research institution in the mid-northern region of the country. As of 2015 it had more than 4,000 employees, including 310 professors, and over 36,000 registered students.
The university is internationally recognised for research on the genome of the poplar tree and the Norway spruce, and its Institute of Design is the only Swedish school on BusinessWeek’s top 60 list of design schools worldwide.
The research was conducted in collaboration with international partners, including the Hospital del Mar Medical Research Institute and the Josep Carreras Leukaemia Research Institute.